ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014

New Criteria For Comprehensive center Status finalized

November 17, 1989

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

Pressure On Reagan To Appoint Scientists to NCAB Increases with Demand From Powerful Congressman

March 9, 1984